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Abstract
Background: Chikungunya has recently been reported by the WHO to account for
many cases in Sudan. The infection is extremely symptomatic, with fever, skin rash,
and incapacitating arthralgia, which can promote chronic arthritis and rheumatism in
older patients. A few studies on chronic pain owing to the Chikungunya virus (CHIKV)
infection have been issued. The aim of this study was to outline the laboratory findings
and the physical symptom frequency of joint pain of the current Sudanese CHIKV
outbreak, and evaluate its impact on the individual.
Methods: This cross–sectional study included 23 CHIKV-confirmed patients attending
a Sudanese single private medical center between March and September 2019. The
included patients were checked for rheumatoid factor (RF) value, C-reactive protein
(CRP) titer, erythrocyte sedimentation rate (ESR) value, and uric acid (UA) level. Physical
scrutiny was conducted and persistent symptoms were registered.
Results: The significant rheumatologic conditions were polyarthralgia 39.1%,
polyarthritis 21.7%, arthralgia 17.4%, arthritis 13%, and osteoarthritis 8.8%. Swelling
signs were noted in 21.9% of the patients. Joints implicated were knees 59.4%, wrists
56.3%, fingers 50%, shoulders 37.5%, feet 34.4%, ankles 31.3%, spine 18.8%, and elbow
9.4%. CRP, RF, and ESR were significantly increased in patients with persistent joints
pain versus non-persistent joint pain patients (P = 0.000, 0.002, 0.008, respectively).
Whereas the UA was insignificant (P = 0.920).
Conclusion: Knee joint pain remarks a significant dilemma post-CHIKV. It is noted that
these remarks were linked with the risk of subsequently creating chronic sequelae.
Polyarthralgia was the dominant inflammatory sequel post-Chikungunya infection.
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1. Introduction
Chikungunya virus (CHIKV) infection is a mosquito-borne disease that can cause prompt
chronic articulations pain and arthritis [1]. CHIKV is an arbovirus transmitted by the bite of
the casualty female of mosquitoes, Aedes aegypti, and Aedes albopictus. Patients with
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severe contagion present with fever, headache, myalgia, rash, and joint pain. Previous
outbreaks have been documented in Africa, Asia, Europe, and the Indian and Pacific
Ocean islands and even Sudan [2]. CHIKV can cause extreme morbidity and, since
2005, scanty fatal cases were quantified [3]. Sudan is an African nation that fringes
the Red Sea and seven nations. The atmosphere in Sudan is hot and dry. In the year
2018, 15 of Sudan’s 18 States have been influenced by overwhelming downpours and
floods among June and early November [2]. The circumstance made great ground for
mosquitoes’ reproduction. The distribution of CHIKV in the overall public is obscure in
Sudan. Sporadic instances of CHIKV having co-infection with Dengue Fever have been
accounted for from Sudan [2]. Nonetheless, high densities of Aedes aegypti have been
recognized in all States of Sudan excluding Khartoum and Northern States [3]. CHIKV
causes both acute and chronic disabling trouble. Beginning weeklong prostrated fevers
are predominantly followed by musculoskeletal and joint pain, frank arthritis, and, more
infrequently eye inflammation, vision loss, Guillain-Barre Syndrome, paralysis, vasculitis,
encephalitis, hepatitis, and/or myopericarditis [4]. The term “Chikungunya” signifies “that
which bends up” about the extreme arthralgia related to the intense period of infection
and the subsequent posture of those afflicted. To date, the exact mechanism for CHIKV’s
incapacitating sequelae stay to be completely obscure. Underlying comorbidities, for
example, cardiovascular disease, hypertension, concomitant osteoarthritis, obesity, and
diabetes have been distinguished as conceivably expanding the seriousness of CHIKV
disease. Likewise, age at the time of extreme infection has been accounted for by many
examiners to be predictive of persistent arthralgia or arthritis after CHIKV infection [5].
Research conducted in the American outbreak explored that 30–70% of CHIKV infected
patients experience persistent joint pain months or years after their severe sickness.
There have been a few statements of the recurrence of chronic joint pain in American [6].
In this study, we examined the laboratory findings and the physical symptom frequency
of joint pain of the current Sudanese CHIKV outbreak and its effect on the individual.
2. Patients and Methods
Thirty-two patients with clinically and laboratory-confirmed CHIKV infection were
recorded as a portion of a prospective cross-sectional study in the period from March
to September 2019. This study was started six months after the end of the current
Sudanese outbreak. The diagnosis of CHIKV was immunologically verified by enzyme-
linked immunosorbent assay (ELISA). A baseline survey was documented to ascertain
exposure history, rheumatologic symptoms, duration of symptoms, number of joints
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affected, and comorbidities. Patients defined as suffering from joint pain were taken to
complete the arthritis disease activity score questionnaire [7]. Individuals who already
have features or confirmed for arthritis, systemic lupus erythematosus (SLE), Sjogren’s
syndrome, sarcoidosis, chronic infection, and cancer were excluded from this study.
All enrolled CHIKV patients were screened for rheumatoid factor (RF) titer, C-reactive
protein (CRP) titer, erythrocyte sedimentation rate (ESR), and serum uric acid level.
2.1. Arthritis Severity Score
The disease activity sequelae in patients were estimated using the internationally vali-
dated disease activity score recommended by the American College of Rheumatology
[7].
2.2. Quality Control
Standard operational procedures (SOPs) were carefully pursued, and quality control
materials were applied for all serological tests. Moreover, the research facility quality
was guaranteed by well-prepared experts and supervision during sample processing.
2.3. Sample Size calculation
The gauging of sample size was calculated using a cross-sectional statistic formula
at 95% CI, 18% marginal errors with 50% of CHIKV distributed in a similar study [8].
A 10% unresponsive rate was likewise used to turn away any errors and expand the
dependability of the findings. The sample size was adjusted to 32.
2.4. Laboratory analysis
For each patient, 3 ml venous blood samples were gathered under an aseptic condition
in sterile plain containers for performing Uric acid level, RF and CRP titers. 2 ml venous
blood samples added to 3.2% Tri-sodium citrate containers in a proportion of 1: 4
forwarded to carried out ESR (Westergren technique).
DOI 10.18502/sjms.v15i3.6823 Page 302
Sudan Journal of Medical Sciences Bashir A. Bashir and Abubaker El-dirdiri
2.5. Data analysis
Data are summarized as mean ± standard deviation for continuous variables and as
the number (percentage) for categorical variables. The Kolmogorov-Smirnov test was
employed to assess the distributions of continuous variables and it exhibited that the
variables were normally distributed for each group. Nonparametric tests, Mann-Whitney
test andWilcoxon signed rank test were used to compare CRP, RF, ESR, and UA between
patients with persistent joint pain and non-persistent joint pain. The Chi-squared test or
Fisher’s exact test was conducted for rheumatological symptoms and diagnosis. Linear
regression was applied to explore the provoke of CRP and RF with the duration of the
disease. The correlation between variables was measured by Spearman’s rank-order
correlation analysis. P< 0.05 was taken statistically significant. Data were analyzed
employing statistical package for social science (SPSS 24.0 version, IBN, Chicago, USA).
3. Results
A total of 32 participants were enrolled and fulfilled the criteria of the study. Of 32
patients, 16 (50%) weremales and 16 (50%) were females. The baseline categories of the
confirmed cases were highlighted in (Table 1). The most frequent baseline comorbidity
was diabetes (13%). The most commonly influenced joints were knees joint, wrists
joint, fingers joint, and shoulders joint (Table 2). The underlying joint pain during the
intense infection lasted a median of 3 months, and numerous patients had sporadic and
persistent joint pain after the initial infection. At the point when patients were arranged
by sex, it was noted that both genders were equally prone to have CHIKV infection
symptoms.
During follow-up, the median duration of joint pain was documented as 3 months. 23
out of 32 patients (71.9%) had persistent joint pain. About 48% of patients with persistent
joint pain were female (Table 1). This study reported up to 6 joint involvements, including
the number of joints implicated and the span of joint symptoms. The elementary infection
was observed the overwhelmed majority of CHIKV infection among the studied 25
(78.1%), whereas recurrent infection was seen only in 7 (21.9%) of the patients. According
to the disease activity score, most of the cases in this study are polyarthralgia (39.1%)
followed by polyarthritis (21.7%), arthralgia (17.4%), and arthritis (13.0%) (Table 1).
The difference between the CHIKV infected patients with persistent joint pain and
non-persistent joint pain was found to be significant in CRP, RF, and ESR (P= 0.000,
0.002, and 0.008, respectively). While Uric acid was insignificant between the two
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groups (P=0.920) (Table 1). ESR was significantly increased in persistent joint pain
(ranged 25 - 50) in 50% of patients. ESR. CRP and RF titer values were ranging between
3 and 60 (median 14.3 mg/liter) and from 4.7 - 24 (median 11.2 IU/ml), respectively.
34.4% of patients with persistent joint pain had a significant increase in RF value which
indicates inflammatory arthritis. 59.4% of persistent joint pain was concerned with high
CRP titer levels. 8 (25%) of patients had high RF and CRP titer values. Moreover, CRP was
not affected by the duration of the disease (P= 0.152), unlike RF which was statistically
increased with the increasing duration of the illness (P= 0. 013). This was highlighted by
regression analysis (Figure 1, 2).
Among the participants in the present report, the most frequent joint pain symptoms
recorded were knee joint pain which was experienced by 59.4% of the patients followed
by wrist joint pain 56.3%, fingers joint pain 50%, shoulder joint pain 37.5%, feet joint pain
34.4%, ankle joint pain 31.3%, swelling 21.9%, spine joint pain 18.8%, and elbow joint pain
9.4%. Interestingly, the knee joint pain symptom represented the signature symptom
post-CHIKV infection (P = 0.000) as well as wrist joint pain (P= 0.001), fingers joint pain
(P= 0.002) (Table 2). However, it is great to note that these remarks were linked with the
risk of subsequently creating chronic sequelae. The statistical elaboration of findings
with the rheumatologic conditions is illustrated in Table 3.
In this report, age was found to be significantly correlated with the number of joint
affected (r = 0.442/ P < 0.011), underlying disease (r = - 0.482/ P < 0.005), and shoulder
joint pain (r = - 0.361/ P = 0.042), and negatively correlated with RF level, CRP level, and
ESR level (r = 0.125/ P < 0.494, r = - 0.032/ P = 0.862, r = 0.176/ P = 0.336, respectively).
A positive correlation was seen in the number of joint affected by ESR level, shoulder
joint pain, and swelling (r = - 0.603/ P < 0.000, r = - 0.501/ P = 0.003, r = - 0.471/ P =
0.007, respectively). Furthermore, a significant correlation was also noted in CRP level
with the number of joint affected, ESR level, knee joint pain, and shoulder joint pain (r
= - 0.720/ P = 0.000, r = 0.700/ P = 0.000, r = - 0.352/ P = 0.048, r = 0.378/ P = 0.033,
respectively), and negatively correlated with the number of joint affected, underlying
disease, RF level, and swelling (r = - 0.004/ P = 0.985, r = 0.129/ P = 0.483, r = 0.197/ P
= 0.280, r = 0.249/ P = 0.115, respectively). On the other hand, the ESR was positively
correlated with CRP (r = 0.545/ P = 0.001) and negatively correlated with RF (r = 0.249/
P = 0.169).
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TABLE 1: Baseline characteristics of the patients serologically confirmed CHIKV classified according to joint
pain status

















































































There are three discerned common genotypes of CHIKV: Asia, East/Central/South Africa,
and West Africa. These genotypes are presented invasively throughout the Indian
Ocean region [8]. Extreme CHIKV infection may cause significant physical impotency
[9]. Therefore, this study was taken to elucidate the rheumatologic sequel of post-
Chikungunya infection.
Arthritis/arthralgia is a flagship feature of CHIKV. Many patients were improved within
a few weeks, but somewhat up to 50% reveal chronic joint pain and/or swelling. Once
rheumatic symptoms persist for ≥ 3 months, this indicates a feature of chronic Chikun-
gunya arthritis [10]. In acute CHIKV infection, many cytokines get abundant such as
interleukin families (1Ra, 1β, 6, 7, 8, 12) as well as interferon-alpha (IFN-α). Therefore, T
cells and the chemokine C-C Ligand 5/regulated on activation, normal T cell expressed
and secreted (RANTES) decreased in severe infection. Chronic Chikungunya arthritis
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may elevate the levels of IL-6, IL-17, and granulocyte-macrophage-colony stimulating
factor (GM-CSF) [11]. IL-17 specifically, may drive chronic joint pain, triggering the upreg-
ulation of the other pro-inflammatory cytokines (IL-1, IL-6, tumor necrosis factor (TNF-α),
and matrix metalloproteinase) prompting osteoclastogenesis and bone disintegrations
[12]. This study explored that both sexes are more likely to prone the risk of persistent
arthralgia/arthritis. This result is not a concordance with other previous studies that
have demonstrated females to be at increased risk for persistent arthralgia/arthritis
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Figure 1: Relationship between C-reactive protein and the duration of CHIKV disease
Figure 2: Relationship between rheumatoid factor and the duration of CHIKV disease
[13-15]. However, this unconformity may be excused due to a shortage of sample
size. 79.1% of our studied members have been fulfilled the definition of persistent
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arthralgia/arthritis, which emphatically consented with an ongoing meta-analysis on
the occurrence of persistent arthralgia officiated by Rodriquez-Morale et al [16]. Their
investigations indicated that in studies with more than 200 members, 34% of CHIKV
infected patients would go on to develop persistent arthritis/arthralgia. This extent
is likewise comparable to that as of the detailed by Feldstein et al [17] and is also
considerable with our findings.
The intensity of CHIKV infection has recently been answered to be predictive of
recovery and long-haul arthritis and arthralgia remarks [18, 19]. Similarly, in our work,
a few severe symptoms, including knee pain, wrist pain, shoulder pain, finger pain,
which are revealed more serious illness were examined as linked to expanded chronic
disease risk. This work highlighted that knee joint pain is a countersign symptom of
the disease. A finding also similar to Chang et al [20]. Thus, shoulder joint pain, wrist
joint pain, finger joint pain, foot joint pain, and ankle joint pain were found significant in
association with CHIKV infection. The prevalence of these symptoms was also explored
in Rodriquez-Morale et al and van Anlst et al [16, 21].
The disease intensity and the following risk of arthralgia/arthritis have been interlinked
with viral burden [22]. Remarkably, post-CHIKV infection sequel depends on the duration
of the disease onset [23], this surveillance was accentuated to our study. Concerning
rheumatologic conditions associated with the present study, polyarthralgia, polyarthritis,
arthralgia, and arthritis were represented the most rheumatologic problems. These
findings are similar to Heath et al and Ganu et al [23, 24]. Laboratory findings such as RF,
CRP, and ESR were found to be significant in association with Chikungunya infection,
this may support the evidence that the presence of increased value of these parameters
is a factor implicated in the progression of Chikungunya complications [23]. Besides, this
study revealed that age and the number of joint affected were also considered factors
that enhance in augments of Chikungunya sequel. A significant increase in CRP results
was noted in 59.4% of the study. These findings concur with Ganu et al [24]. ESR was
elevated in 50% of patients as a screening marker of inflammation. RF was significantly
positive in 34.4%. A determination was also likewise detected previously [20, 24]. The
high titer of RF could be falsely positive or its output could have been activated by
CHIKV disease [24]. This study was subject to some limitations summarized as, this
is a short communication survey with very limited sample size, in addition to that, we
have neglected other physical symptoms of individuals who did not seek consultation.
Recall bias could not be ruled out. A prospective study with considerable expansion
should be planned to monitor the structural joint damage, the therapeutic drugs used,
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combined molecular and serological characterization of CHIKV, and more laboratory
sophisticated analyses.
5. Conclusion
Polyarthralgia was characterized as the dominant inflammatory sequel in this study,
followed by polyarthritis, and arthralgia for at least 3months. Knee joint pain represented
a significant dilemma post-CHIKV infection. Effective cure post-CHIKV symptoms sequel
could improve the health of an individual.
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